Covid Vaccines for Children in India Soon: All You Need To Know

Covid vaccines are also important for kids to return to schools safely, which have been shut for nearly 15 months

Covid Vaccines for Children in India Soon: All You Need To Know

With new variants of COVID-19 spreading at an alarming rate all over the world, vaccinating children is being seen as key to break the chain of transmission.

There is also growing concern regarding the rise in cases of coronavirus among kids and the subsequent post-Covid complications.

Vaccines are also important for kids to return to schools safely, which have now been shut for nearly 15 months since the pandemic began last year.

Addressing concerns around the reopening of schools in some states, AIIMS Director Dr Randeep Guleria recently said the shots should be made available by September for children.

Let's take a look at all the COVID-19 vaccines that may be available for children in India soon.


Zydus Cadila

Zydus Cadila has concluded its trials for those aged between 12-18 and has applied for emergency use authorisation of its DNA-plasmid vaccine.

The Ahmedabad-based drug company has submitted safety and tolerability data from the phase 2 clinical trials and has generated data on 1,000 adolescents from its phase 3 trials.

Officials have said that if the approval is provided, supply of the vaccine is expected to start by August-September, according to reports.

Bharat Biotech's Covaxin

Indigenous vaccine maker Bharat Biotech is also carrying out phase 2-3 trials of its whole virus vaccine, Covaxin, on children in the age group of 2-18 years.

“The outcome of these trials will depend on data emerging from the trial for the purpose of its approval and availability in the country,” Union Minister of State for Health Bharti Pawar told the Lok Sabha.

Meanwhile, the AIIMS chief has said that the results of the Covaxin trials are expected by September, according to reports.


The US Food and Drug Administration (FDA) has authorised Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years old, in May.

However, Pfizer has been insisting on an indemnity clause before agreeing to supplying the Covid-19 vaccines to India.

The AIIMS chief said that the Pfizer vaccine can also be an option for children in India, once it gets the nod.


Last month, the European medicines watchdog approved the use of Moderna's mRNA COVID-19 vaccine for children aged 12 to 17.

The EU drug regulator said the Spikevax vaccine was found safe for children aged 12 to 17 years and produced a comparable antibody response as seen in young adults aged 18 to 25 years.

However, legal hurdles need to be sorted out for its vaccines to be available in India.

Sputnik V

Trials of Russia’s Sputnik V COVID-19 vaccine for children aged between 12 to 17 years, are on currently in Moscow.

While Sputnik vaccines for adults are available in India, there have been no talks for shots for children, according to reports.

(Subscribe to FIT on Telegram)

Stay Up On Your Health

Subscribe To Our Daily Newsletter Now.

Join over 120,000 subscribers!